John Wagner

Sources

Sources are listed once and connected to each accepted claim they support. Excerpts preserve the source language used in the review.

1. [1]

   2026 ATLAS Cohort | Clinical and Translational Science Collaborative (CTSC) | Case Western Reserve University

   4 source claims · Reviewed Sep 9, 2026

   Show supporting evidence

   Degree: MD

   John Wagner, MDMetroHealth Medical CenterHematological Malignancy and Cellular Therapy Director, Cancer Center Clinical Trials Office, MetroHealthProfessor, Department of Medicine, CWRU

   Identity: John Wagner

   John Wagner, MDMetroHealth Medical CenterHematological Malignancy and Cellular Therapy Director, Cancer Center Clinical Trials Office, MetroHealthProfessor, Department of Medicine, CWRU

   Professional role: Hematological Malignancy and Cellular Therapy Director, Cancer Center Clinical Trials Office, MetroHealth

   John Wagner, MDMetroHealth Medical CenterHematological Malignancy and Cellular Therapy Director, Cancer Center Clinical Trials Office, MetroHealthProfessor, Department of Medicine, CWRU

   Hematological Malignancy and Cellular Therapy Director, Cancer Center Clinical Trials Office, MetroHealth

   Professional role: Professor, Department of Medicine, CWRU

   John Wagner, MDMetroHealth Medical CenterHematological Malignancy and Cellular Therapy Director, Cancer Center Clinical Trials Office, MetroHealthProfessor, Department of Medicine, CWRU